from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2999/lppY

LFCtreatmentdescriptionclass of inhibitor

0.988

Amikacinug/mL Amikacintranslation

2.052

Cap5-10ug/mL Capreomycintranslation

1.737

Rox10-50 ug/mL Roxithromycintranslation

1.362

SM2-5 ug/mL Streptomycintranslation

1.059

Tet5-10 ug/mL Tetracyclinetranslation

-0.100

Rif0.2-5ug/mL Rifampicintranscription

-0.157

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.187

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.514

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.131

CPZ10-50 ug/mL Chlorpromazinerespiration

-2.293

Clofazimine10-13 ug/mL Clofaziminerespiration

0.202

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.786

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.975

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.975

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.023

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.933

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.362

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.076

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.943

KCN5-20 ug/mL Potassium cyaniderespiration

-0.896

NaN30.2-2 mM Sodium aziderespiration

1.459

Nigericin50 uM Nigericinrespiration

-0.411

TRC10-150 ug/mL Triclosanrespiration

-0.603

TRZ10-25 ug/mL Thioridazinerespiration

1.154

Valinomycin0.5-10 uM Valinomycinrespiration

-0.958

ZnSO42 mM ZnSO4respiration

0.804

menadione6-10 ug/mL Menadionerespiration

-0.246

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.507

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.092

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.154

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.052

NRP_1Non-replicating persistence stage 1dosRassociated

0.574

Amp0.2mg/mL AmpicillincellWall

0.143

Cephalexin20-100 ug/mL CephalexincellWall

0.190

Cerulenin0.32-5 ug/mL CerulenincellWall

0.644

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.414

EMB10-20 ug/mL EthambutolcellWall

0.141

Eta12-40 ug/mL EthionamidecellWall

0.072

INH0.2-0.4 ug/mL IsoniazidcellWall

0.295

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.202

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.349

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.145

BZA0.12 mg/mL BenzamidearomaticAmides

0.214

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.157

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.432

H2O24 mM hydrogen peroxideDNAdamaging

0.097

Levo10 ug/mL LevofloxacinDNAdamaging

0.772

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.580

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.561

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.024

UVUV-irradiationDNAdamaging

-1.737

ARP41-4 ug/mL Antitubercular compound ARP4?

0.747

Antimycin12.5-50 ug/mL Antimycin A?

0.666

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.282

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.044

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.690

PA8240.2-2 ug/mL PA-824?

-0.379

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.044

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.117

Verapamil50 uM Verapamil?

0.981

mercaptoethanol2 mM 2-Mercaptoethanol?

0.483

methoxatin10-20 ug/mL Methoxatin?